Publication date: Available online 3 November 2026 Source: European Annals of Otorhinolaryngology, Head and Neck Diseases Author(s): M. Rotolo, C. Lancellotti, F. Mattioli, L. Trudu
Severe pembrolizumab-induced lichenoid mucositis with durable complete response in recurrent head and neck squamous cell carcinoma. // European Annals of Otorhinolaryngology, Head and Neck Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1879729626001961?dgcid=rss_sd_all
Severe pembrolizumab-induced lichenoid mucositis with durable complete response in recurrent head and neck squamous cell carcinoma. European Annals of Otorhinolaryngology, Head and Neck Diseases. https://www.sciencedirect.com/science/article/pii/S1879729626001961?dgcid=rss_sd_all
“Severe pembrolizumab-induced lichenoid mucositis with durable complete response in recurrent head and neck squamous cell carcinoma.” European Annals of Otorhinolaryngology, Head and Neck Diseases.
@article{article44653,
title = {Severe pembrolizumab-induced lichenoid mucositis with durable complete response in recurrent head and neck squamous cell carcinoma},
journal = {European Annals of Otorhinolaryngology, Head and Neck Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1879729626001961?dgcid=rss_sd_all}
}